Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
agenus
Oct 24, 2023, 14:05 |
Drugs
Agenus is proud to unveil the latest research from our investigational botensilimab programs - Agenus
Agenus shared a post on LinkedIn: "Agenus is proud to unveil the latest research from…
Oct 15, 2023, 14:10 |
Blog
Jennifer Buell: SaponiQx, an Agenus Inc. company revolutionizes access with sustainable, scalable supply of the vital QS-21 STIMULON
Jennifer Buell, President and Chief Executive Officer at MiNK Therapeutics, shared on X/Twitter: "SaponiQx, an Agenus…
Oct 11, 2023, 22:39 |
Opinion
Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer. - Agenus
Sep 21, 2023, 17:50 |
Insight
TIGIT bispecific program is advancing in clinical trials for non-small cell lung and gastric cancers. - Agenus
Agenus shared on LinkedIn: “Our partner, Bristol Myers Squibb, unveiled exciting updates at their recent…
Aug 22, 2023, 18:09 |
Career
Beatrice Duvert: I’m happy to share that I’m starting a new position as an Associate Program Manager at Agenus!
Quoting Beatrice Duvert, Associate Program Manager at Agenus, on LinkedIn: "I’m happy to share that…
Aug 14, 2023, 18:19 |
Insight
Tune in to "Innovation Unleashed: Exploring the Intersection of Science and Creativity - An Unconventional Growth Strategy" - Agenus
Quoting from Agenus LinkedIn: ''Thank you, Sabine Hutchison, for hosting us on an insightful episode of…
Jul 29, 2023, 17:45 |
Blog
Agenus is thrilled to welcome the newest members of executive leadership team
Agenus is thrilled to welcome the newest members of our executive leadership team: Robin Taylor,…
Jul 1, 2023, 06:00 |
Drugs
Agenus’ botensilimab/balstilimab combination achieves unprecedented survival in advanced colorectal cancer
In a post by Agenus on Linkedin, it says, "ESMO Late-Breaking GI Data: Agenus’ botensilimab/balstilimab…
May 14, 2023, 06:04 |
Career
Beth Wensley is appointed as Associate Director of Protein Sciences at Agenus
"Introducing Beth Wensley, our Associate Director of Protein Sciences. As one of Agenus' original employees…
Sep 24, 2024, 16:52 |
Blog
Assessment of the safety and efficacy of Balstilimab in combination with Botensilimab for NSCLC - Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: ''Assessment of the safety and efficacy…
4
5
6
7
8
All:
112
Posts:
51 - 60
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube